Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Entera Bio Ltd., a foreign private issuer, covers the month of March 2021. The report, dated March 18, 2021, consists solely of a press release attached as Exhibit 99.1. The registrant is headquartered in Jerusalem, Israel, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a vehicle to incorporate a press release by reference and does not contain a financial statement or quantitative financial data within the provided text.
Material Changes
No material changes to financial performance or operations are detailed in the provided text. The document functions as a procedural filing to incorporate an external press release into the company's registration statements (Form F-3).
Guidance, Outlook, and Risks
The provided text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These details would be contained within the referenced press release (Exhibit 99.1), the content of which is not included in the input.
Key Facts for Investors to Verify
- Review the full text of the press release dated March 18, 2021 (Exhibit 99.1) to understand the specific corporate event or announcement triggering this filing.
- Verify the incorporation of this report into the company's active Form F-3 registration statements (Nos. 333-238988 and 333-239843).
- Confirm that no financial data is presented in this specific Form 6-K text, requiring a review of the latest Form 20-F or 10-Q for financial metrics.